Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Kontafarma China Holdings Ltd ( (HK:1312) ) has shared an announcement.
Kontafarma China Holdings has issued a supplemental notice for its annual general meeting, scheduled for 5 June 2026 in Hong Kong, to update shareholders on changes to one of the meeting’s resolutions. The company is now proposing the re-election of three executive directors, one non-executive director and one independent non-executive director, effectively refreshing and confirming its existing board composition.
The supplemental notice clarifies that the original resolution item concerning director elections is being replaced, and a revised proxy form has been circulated to shareholders to reflect the updated slate. All other matters to be considered at the AGM remain unchanged, indicating that the primary impact of this announcement is procedural, focused on ensuring proper corporate governance and accurate shareholder voting documentation.
More about Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd is a Cayman Islands–incorporated company listed in Hong Kong, with its head office in Wanchai, Hong Kong. The board currently consists of three executive directors, one non-executive director and three independent non-executive directors, reflecting a typical governance structure for a Hong Kong–listed firm.
Average Trading Volume: 1,544,460
Technical Sentiment Signal: Sell
Current Market Cap: HK$161.8M
Learn more about 1312 stock on TipRanks’ Stock Analysis page.